Skip to main content
George Daley, MD, Hematology, Boston, MA

GeorgeQDaleyMD

Hematology Boston, MA

Professor of Biological Chemistry and Molecular Pharmacology, Boston Children's Hospital

Dr. Daley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Daley's full profile

Already have an account?

  • Office

    300 Longwood Ave
    Boston, MA 02115
    Phone+1 617-919-2013
    Fax+1 617-730-0222

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1994
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1991 - 1993
  • Harvard Medical School
    Harvard Medical SchoolClass of 1991

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1993 - 2025

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2011
  • Elected Member The American Society for Clinical Investigation, 2003
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The Toughest Triage — Allocating Ventilators in a Pandemic  
    Robert D Truog, George Q Daley, The New England Journal of Medicine
  • The Toughest Triage — Allocating Ventilators in a Pandemic  
    Robert D Truog, George Q Daley, The New England Journal of Medicine

Abstracts/Posters

  • Ezh1 Inhibits Commitment to Hemogenic Fate and HSPC Formation during Vertebrate Development
    George Q. Daley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Completing the Genome Editing Arc in Hematology 
    60th American Society of Hematology Annual Meeting - 12/4/2018

Press Mentions

  • Making Ionocytes: A Step Toward Cell or Gene Therapy for Cystic Fibrosis
    Making Ionocytes: A Step Toward Cell or Gene Therapy for Cystic FibrosisApril 21st, 2023
  • 5 Medical Schools Withdraw From US News' Rankings
    5 Medical Schools Withdraw From US News' RankingsJanuary 24th, 2023
  • Harvard Medical School Joins Boycott of U.S. News Rankings
    Harvard Medical School Joins Boycott of U.S. News RankingsJanuary 18th, 2023
  • Join now to see all

Grant Support

  • Customized Stem Cells For Clinical Application In Blood DisordersNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Human Pluripotent Stem Cell And Progenitor Models Of Cardiac And Blood DiseasesNational Heart, Lung, And Blood Institute2009–2011
  • Novel Therapies For Fanconi AnemiaNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Second International Conference On Stem Cell EngineeringNational Heart, Lung, And Blood Institute2010
  • Comparative Phenotypic, Functional, And Molecular Analysis Of ESC And IPSCNational Heart, Lung, And Blood Institute2009–2010
  • Murine Models For Regenerative MedicineNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Hematopoietic Stem Cells From Pluripotent Embryonic Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • NIH Director'S Pioneer AwardOffice Of The Director, National Institutes Of Health2005–2008
  • Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2004–2005
  • Modeling Developmental Hematopoiesis With Embryonic StemNational Heart, Lung, And Blood Institute2003–2005
  • NIH Director'S Pioneer Award (RMI)Office Of The Director, National Institutes Of Health2004
  • Hematopoietic Stem Cells From Totipotent Stem Cell TypesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
  • Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2003
  • Modeling Developmental Hematopoiesis With Embryonic StemNational Heart, Lung, And Blood Institute2002–2003
  • Hematopoietic Stem Cells From Totipotent Stem Cell TypesNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
  • Therapeutic Mechanisms In Chronic Myelogenous LeukemiaNational Cancer Institute2001–2003
  • Molecular Pathways In Myeloproliferative DiseaseNational Cancer Institute1998–2002